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Introduction: Virtual reality (VR) shows significant potential as a healthcare tool, especially in the
management of anxiety disorders and pain. However, despite recent studies demonstrating the effectiveness
of VR, there continues to be limited use among providers. A lack of resources and understanding of the
feasibility of clinical VR use may present a significant barrier for VR implementation. Through studying
the perceptions of providers using VR clinically, this study aims to understand the achievability of VR as a
standardized therapy.
Methods: Researchers distributed an online, self-administered questionnaire to healthcare providers
identified on VR application websites. The questionnaire consisted of five sections including respondent
demographics, VR value, onboarding, billing, and clinical use. Inclusion criteria was providers in the United
States using VR actively or in the past year as a therapeutic tool. Exclusion criteria was providers in other
countries or providers who did not have email access. Twenty-two responses were received, and four
excluded.
Results: The most commonly cited use of VR among providers was acute pain/anxiety (N=11, 61.1%)
treatment, followed by specific and social phobia (N=6, 33.3% each). In relation to the onboarding process,
the slight majority (N=10, 58.8%) of providers did not find transitioning to VR difficult. Of those who did,
cost was the most commonly cited barrier. Most providers (N=15, 88.2%) received training on their VR
platform which they found beneficial.
Discussion: While VR is a treatment adjunct that is well-received by patients and providers, associated
costs may present the largest barrier to implementation.

